2.6
2023

Cost-effectiveness of the SQ HDM SLIT-tablet for the treatment of allergic asthma in three Eastern European Countries

Show more: Authors information and Publication history
Authors Information

1York Health Economics Consortium, Enterprise House, Innovation Way, University of York, Heslington, York, UK
2St. Elisabeth University, Institute of Healthcare Disciplines, Bratislava, Slovakia
3ALK-Abelló, Denmark
*RB was an employee of ALK-Abelló at the time when this research was conducted.

 

History


Published online: 12 November 2018
Accepted: 10 October 2018
Received:20 July 2018

KEY WORDS
cost-effectiveness; allergic asthma; allergy immunotherapy; sublingual immunotherapy; SQ HDM SLIT-tablet

Table of Content: Vol. 51 (No. 2) 2019 March

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024